Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph early_phase_1
1
33%
Ph not_applicable
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownearly_phase_1

Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

NCT03095469
unknownnot_applicable

Effects of Dexmedetomidine on Postoperative Renal Function Recovery After Kidney Transplantation in Adult Patients

NCT02874378
unknownnot_applicable

Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients

NCT02644915

Clinical Trials (3)

Showing 3 of 3 trials
NCT03095469Early Phase 1

Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

Unknown
NCT02874378Not Applicable

Effects of Dexmedetomidine on Postoperative Renal Function Recovery After Kidney Transplantation in Adult Patients

Unknown
NCT02644915Not Applicable

Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3